Alliancebernstein L.P. Acquires 4,560 Shares of Sotera Health (NASDAQ:SHC)

Alliancebernstein L.P. lifted its holdings in Sotera Health (NASDAQ:SHC) by 2.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 209,823 shares of the company’s stock after acquiring an additional 4,560 shares during the quarter. Alliancebernstein L.P. owned 0.07% of Sotera Health worth $2,870,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Sotera Health by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company’s stock worth $204,154,000 after purchasing an additional 173,341 shares during the period. State Street Corp raised its holdings in Sotera Health by 18.5% during the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock valued at $68,918,000 after buying an additional 644,236 shares during the last quarter. Geode Capital Management LLC boosted its position in Sotera Health by 19.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after buying an additional 447,186 shares during the period. Bank of New York Mellon Corp grew its holdings in Sotera Health by 45.1% in the 4th quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company’s stock worth $22,308,000 after acquiring an additional 507,147 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Sotera Health in the fourth quarter valued at about $12,764,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Down 1.1 %

Shares of Sotera Health stock opened at $10.50 on Wednesday. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 12-month low of $9.53 and a 12-month high of $17.08. The company has a market cap of $2.98 billion, a P/E ratio of 42.00 and a beta of 1.88. The company’s fifty day simple moving average is $12.02 and its two-hundred day simple moving average is $13.44.

Analyst Ratings Changes

Separately, Barclays dropped their target price on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $15.20.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.